Nifedipine suppresses morphine-induced thermal hyperalgesia: Evidence for the role of corticosterone

European Journal of Pharmacology

Volumn 567, Issue 1-2, 2007, Pages 95-101

  Esmaeili Mahani, Saeed ^a,b   Fereidoni, Masoud ^c,d   Javan, Mohammad ^c   Maghsoudi, Nader ^a   Motamedi, Fereshteh ^a   Ahmadiani, Abolhasan ^a  

^a SHAHID BEHESHTI UNIVERSITY OF MEDICAL SCIENCES   (Iran)

^b SHAHID BAHONAR UNIVERSITY OF KERMAN   (Iran)

^c TARBIAT MODARES UNIVERSITY   (Iran)

^d FERDOWSI UNIVERSITY OF MASHHAD   (Iran)

Author keywords

Corticosterone; Hyperalgesia; L type calcium channel; Morphine; Nifedipine

Indexed keywords

CALCIUM CHANNEL; CORTICOSTERONE; DIHYDROPYRIDINE DERIVATIVE; MORPHINE; NIFEDIPINE;

ADRENALECTOMY; ANALGESIC ACTIVITY; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CORTICOSTEROID RELEASE; CORTICOSTERONE BLOOD LEVEL; DRUG EFFECT; DRUG INHIBITION; DRUG SUBSTITUTION; DRUG WITHDRAWAL; HYPERALGESIA; HYPOTHALAMUS HYPOPHYSIS ADRENAL SYSTEM; MALE; MODULATION; NONHUMAN; PAIN THRESHOLD; PRIORITY JOURNAL; RAT; TAIL FLICK TEST; TEMPERATURE;

ADRENALECTOMY; ANALGESICS, OPIOID; ANIMALS; CALCIUM CHANNEL BLOCKERS; CORTICOSTERONE; DOSE-RESPONSE RELATIONSHIP, DRUG; HEAT; HYPERALGESIA; HYPOTHALAMO-HYPOPHYSEAL SYSTEM; MALE; MORPHINE; NIFEDIPINE; PAIN THRESHOLD; PITUITARY-ADRENAL SYSTEM; RATS; RATS, WISTAR;

EID: 34249044797     PISSN: 00142999     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.ejphar.2007.03.042     Document Type: Article

References (46)

1. Angst M.S., Koppert W., Pahl I., Clark D.J., and Schmelz M. Short-term infusion of the mu-opioid agonist remifentanil in humans causes hyperalgesia during withdrawal. Pain 10 (2003) 49-57
2. 2+ influx in rat spinal cord-dorsal root ganglion co-cultures: involvement of a GTPbinding protein. J. Biol. Chem. 264 (1989) 347-353
3. Assi A.A. The influence of divalent cations on the analgesic effect of opioid and non-opioid drugs. Pharmacol. Res. 43 (2001) 521-529
4. Bogdanov A.I., and Yarushkina N.I. The role of adrenocorticotropic hormone in the inhibition of pain reactions in conscious rats. Neurosci. Behav. Physiol. 34 (2004) 575-578
5. Buckingham J.C., and Cooper T.A. Pharmacological characterization of opioid receptor influencing the secretion of corticotropin releasing factor in the rat. Neuroendocrinology 38 (1984) 411-417
6. Candido J., Lutfy K., Billings B., Sierra V., Duttaroy A., Inturrisi C.E., and Yoburn B.C. Effect of adrenal and sex hormones on opioid analgesia and opioid receptor regulation. Pharmacol. Biochem. Behav. 42 (1992) 685-692
7. Capasso A., Di Giannuario A., Loizzo A., Pieretti S., and Sorrentino L. Dexamethasone influence on morphine-induced analgesia in outbred Swiss and inbred DBA/2J and C57BL/6 mice. Prog. Neuropsychopharmacol. Biol. Psychiatry 18 (1994) 779-792
8. Casey G., Nortcliffe S.A., Sharpe P., and Buggy D.J. Perioperative nimodipine and postoperative analgesia. Anesth. Analg. 102 (2006) 504-508
9. Celerier E., Rivat C., Jun Y., Laulin J.P., Larcher A., Reynier P., and Simonnet G. Long-lasting hyperalgesia induced by fentanyl in rats: preventive effect of ketamine. Anesthesiology 92 (2000) 465-472
10. 2+ channels in rat dorsal root ganglia neurons through protein kinase C. Neuroscience 128 (2004) 347-357
11. 2+ in SH-SY5Y cells. Brain Res. 882 (2000) 256-265
12. Compton P., Athanasos P., and Elashoff D. Withdrawal hyperalgesia after acute opioid physical dependence in nonaddicted humans: a preliminary study. J. Pain 4 (2003) 511-519
13. Crain S.M., and Shen K.F. Acute thermal hyperalgesia elicited by low dose morphine in normal mice is blocked by ultra-low-dose naltrexone, unmasking potent opioid analgesia. Brain Res. 888 (2001) 75-82
14. D'Amour F.E., and Smith D.L. A method of determining loss of pain sensation. J. Pharmacol. Exp. Ther. 27 (1941) 74-79
15. Dogrul A., Yesilyurt O., Isimer A., and Erdal Guzeldemir M. L-type and T-type calcium channel blockade potentiate the analgesic effects of morphine and selective mu opioid agonist, but not to selective delta and kappa agonist at the level of spinal cord in mice. Pain 93 (2001) 61-68
16. Dogrul A., Bilsky E.J., Ossipov M.H., Lai J., and Porreca F. Spinal L-type calcium channel blockade abolishes opioid-induced sensory hypersensitivity and antinociceptive tolerance. Anesth. Analg. 101 (2005) 1730-1735
17. Esmaeili Mahani S., Motamedi F., Javan M., and Ahmadiani A. Involvement of hypothalamic pituitary adrenal axis on the effects of nifedipine in the development of morphine tolerance in rats. Pharmacol. Biochem. Behav. 81 (2005) 152-157
18. Esmaeili Mahani S., Vahedi S., Motamedi F., Pourshanazari A., Khaksari M., and Ahmadiani A. Nifedipine potentiates antinociceptive effects of morphine in rats by decreasing hypothalamic pituitary adrenal axis activity. Pharmacol. Biochem. Behav. 82 (2005) 17-23
19. Galeotti N., Stefano G.B., Guarna M., Bianchi E., and Ghelardini C. Signaling pathway of morphine induced acute thermal hyperalgesia in mice. Pain 123 (2006) 294-305
20. Guignard B., Bossard A.E., Coste C., Sessler D.I., Lebrault C., Alfonsi P., Fletcher D., and Chauvin M. Acute opioid tolerance: intraoperative remifentanil increases postoperative pain and morphine requirement. Anesthesiology 93 (2000) 409-417
21. Johnson E.E., Chieng B., Napier I., and Connor M. Decreased mu-opioid receptor signalling and a reduction in calcium current density in sensory neurons from chronically morphine-treated mice. Br. J. Pharmacol. 148 (2006) 947-955
22. Karst H., Nair S., Velzing E., Rumpff-van Essen L., Slagter E., Shinnick-Gallagher P., and Joels M. Glucocorticoids alter calcium conductance and calcium channel subunit expression in basolateral amygdala neuron. Eur. J. Neurosci. 16 (2002) 1083-1089
23. Laulin J.P., Larcher A., Celerier E., Le Moal M., and Simonnet G. Long lasting increased pain sensitivity in rat following exposure to heroin for the first time. Eur. J. Neurosci. 10 (1998) 782-785
24. Laulin J.P., Maurette P., Corcuff J.B., Rivat C., Chauvin M., and Simonnet G. The role of ketamine in preventing fentanyl-induced hyperalgesia and subsequent acute morphine tolerance. Anesth. Analg. 94 (2002) 1263-1269
25. Lorentz M., Hedlund B., and Arhem P. Morphine activates calcium channels in cloned mouse neuroblastoma cell lines. Brain Res. 445 (1988) 157-159
26. 2+ uptake and myofibrilar disassembly in primary muscle cell culture. Biosci. Biotechnol. Biochem. 67 (2003) 244-249
27. 2+ channel ligands modulate morphine effects on the hypothalamus-pituitary-adrenocortical axis in rats. Eur. J. Pharmacol. 232 (1993) 191-198
28. Mazorow D.L., Simpkins C.O., and Millar D.B. Beta-endorphin modulates calcium channel activity in human neutrophils. J. Neuroimmunol. 50 (1994) 77-83
29. Milanes M.V., Puig M.M., and Vargas M.L. Simultaneous changes in hypothalamic catecholamine level and plasma corticosterone concentration in rat after acute morphine and during tolerance. Neuropeptides 24 (1993) 279-284
30. Miyamoto Y., Ozaki M., and Yamamoto H. Effect of adrenalectomy on correlation of analgesia with tissue content of morphine. Eur. J. Pharmacol. 167 (1989) 11-20
31. Miyamoto Y., Ozaki M., Kishioka S., Yamanishi T., Kitabata Y., Morita N., and Yamamoto H. Adrenalectomy-induced potentiation of morphine analgesia: reversal by prednisolone. Pharmacol. Biochem. Behav. 37 (1990) 703-706
32. Nestler E.J. Molecular mechanisms of drug addiction. Neuropharmacology 47 (2004) 24-32
33. Pirnik Z., Schwendt M., and Jezova D. Single dose of morphine influences plasma corticosterone and gene expression of main NMDA receptor subunit in the adrenal gland but not in the hippocampus. Endocr. Regul. 35 (2001) 187-193
34. 2+ channel and adenylyl cyclase modulation by cloned mu-opioid receptors in GH3 cells. Mol. Pharmacol. 47 (1995) 1041-1049
35. 2+ channels in GH3 cells by cloned mu- and delta-opioid receptors. Mol. Pharmacol. 50 (1996) 947-956
36. Prado W.A. Involvement of calcium in pain and antinociception. Braz. J. Med. Biol. Res. 34 (2001) 449-461
37. Shen K.F., and Crain S.M. Dual opioid modulation of the action potential duration of mouse dorsal root ganglion neurons in culture. Brain Res. 491 (1989) 227-242
38. Shimizu N., Kishioka S., Maeda T., Fukazawa Y., Yamamoto C., Ozaki M., and Yamamoto H. Role of pharmacokinetic effects in the potentiation of morphine analgesia by l-type calcium channel blockers in mice. J. Pharmacol. Sci. 94 (2004) 240-245
39. Takenaka Y., Nakamura F., Usui H., Lipkowski A.W., Toth G., and Yoshikawa M. Anti-analgesic activity of enterostatin (VPDPR) is mediated by corticosterone. Peptides 24 (2003) 735-739
40. Van Elstraete A.C., Sitbon P., Trabold F., Mazoit J.X., and Benhamou D.A. Single dose of intrathecal morphine in rats induces long-lasting hyperalgesia: the protective effect of prior administration of ketamine. Anesth. Analg. 101 (2005) 1750-1756
41. Vargas M.L., Martinez-Pinero M.G., and Milanes M.V. Neurochemical activity of noradrenergic neurons and pituitary-adrenal response after naloxone-induced withdrawal: the role of calcium channels. Naunyn-Schmiedeberg's Arch. Pharmacol. 355 (1997) 501-506
42. Vissers K.C., De Jongh R.F., Crul B.J., Vinken P., and Meert T.F. Adrenalectomy affects pain behavior of rats after formalin injection. Life Sci. 74 (2004) 1243-1251
43. Xiao G.S., Zhou J.J., Wang G.Y., Cao C.M., Li G.R., and Wong T.M. In vitro electrophysiologic effects of morphine in rabbit ventricular myocytes. Anesthesiology 103 (2005) 280-286
44. Yaksh T.L., and Rudy T.A. Analgesia mediated by a direct spinal action of narcotics. Science 192 (1976) 1357-1358
45. 2+ channel. Acta Pharmacol. Sin. 21 (2000) 156-160
46. Zimmermann M. Ethical guidelines for investigations of experimental pain in conscious animals. Pain 16 (1983) 109-110